Nicolas Barthelemy Repligen Corp (RGEN) insider trading activity

Nicolas Barthelemy is of REPLIGEN CORP. Currently has a direct ownership of 4,441 shares of RGEN, which is worth approximately $527,812. The most recent transaction as insider was on May 15, 2025, when has been sold 973 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.44K

4.86% 3M change

4.86% 12M change

Total Value Held $527,812

NICOLAS BARTHELEMY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2025	BUY Grant, award, or other acquisition	-	973 Added 17.97%	4,441 Common Stock
Jun 14 2024	BUY Open market or private purchase	$150,540 $125.45 p/Share	1,200 Added 20.45%	4,668 Common Stock
May 16 2024	BUY Grant, award, or other acquisition	-	701 Added 16.81%	3,468 Common Stock
May 18 2023	BUY Grant, award, or other acquisition	-	686 Added 19.87%	2,767 Common Stock
May 26 2022	BUY Grant, award, or other acquisition	-	534 Added 20.42%	2,081 Common Stock
Oct 29 2021	SELL Open market or private sale	$474,089 $288.2 p/Share	1,645 Reduced 51.54%	1,547 Common Stock
Oct 29 2021	BUY Exercise of conversion of derivative security	$164,711 $128.18 p/Share	1,285 Added 28.7%	3,192 Common Stock
May 13 2021	BUY Grant, award, or other acquisition	-	457 Added 19.33%	1,907 Common Stock
Nov 09 2020	SELL Open market or private sale	$237,349 $195.51 p/Share	1,214 Reduced 45.57%	1,450 Common Stock

Also insider at

MASS

908 Devices Inc. Healthcare

TWST

Twist Bioscience Corp Healthcare

LAB

STANDARD BIOTOOLS INC. Healthcare

Director